價格 | ¥197 | ¥455 | ¥728 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-07-28 |
中文名稱:化合物 P7C3 | 英文名稱:P7C3 |
CAS:301353-96-8 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.6% | 產(chǎn)品類別: 抑制劑 |
貨號: T1880 |
名稱 | P7C3 |
描述 | The P7C3 class of neuroprotective aminopropyl carbazoles has been shown to block neuronal cell death in models of neurodegeneration. We now show that P7C3 molecules additionally preserve axonal integrity after injury, before neuronal cell death occurs, in a rodent model of blast-mediated traumatic brain injury (TBI). This protective quality may be linked to the ability of P7C3 molecules to activate nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in nicotinamide adenine dinucleotide salvage. |
激酶實(shí)驗(yàn) | To assess the effect of compounds on auto-PARsylation of TNKS, 1 μM GST fusion protein containing the SAM domain and the PARP domain of TNKS2 (a.a. 872-1166) is mixed with 5 μM biotin-NAD+ and 2 μM XAV939 or LDW643 at 30°C for 2.5 hours. Samples are resolved by SDS-PAGE and probed with streptavidin AlexaFluor680. To assess PARsylation of axin, recombinant full-length TNKS2 (expressed/purified as a N-terminal His-tagged protein in bacteria) is incubated with GST-axin 1 (1-280) in the presence of biotin-NAD+ with or without XAV939. The products are resolved and probed with Streptavidin-HRP and imaged using a AlphaInnotech imager. To assess the effect of XAV939, IWR-1-enod, IWR-1-exo, and ABT-888 on auto-PARsylation of TNKS2, His-tagged full-length TNKS2 is incubated with 5 μM biotin-NAD+ and 3 mM of indicated compounds. The products are resolved and probed with Streptavidin-HRP. LC/MS-based high throughput auto-PARsylation assays for PARP1, PARP2, TNKS1, and TNKS2 are setup to monitor the formation of nicotinamide (a by-product of the PARsylation reaction) in the presence of small molecule inhibitors. |
體外活性 | In U2OS Cells, P7C3 protects cells from doxorubicin-mediated toxicity, and enhances the flux of nicotinamide through the NAMPT-mediated salvage pathway. [1] |
體內(nèi)活性 | In mouse brain, P7C3 (40 mg/kg, p.o.) induces neurogenesis and enhances survival of newborn neurons. In npas3?/? mice, P7C3 (20 mg/kg/d, p.o.) increases the magnitude of neural precursor cell proliferation, and corrects morphological and electrophysiological deficits. [2] In the Ts65Dn mouse model of Down Syndrome, P7C3 restores hippocampal neurogenesis though a significant increase in total Ki67+, DCX+, and surviving BrdU+ cells. [3] |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | Ethanol : 16 mg/mL (33.74 mM), Sonication is recommended. DMSO : 88 mg/mL (185.58 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) |
關(guān)鍵字 | Parkinson's | P-7C3 | P7C3 | nicotinamide phosphoribosyltransferase | neuroprotective | neurodegenerative diseases | neurodegeneration | nerve | injury | Inhibitor | inhibit | disease | cell |
相關(guān)庫 | 神經(jīng)保護(hù)化合物庫 | 血腦屏障通透化合物庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 干細(xì)胞分化化合物庫 | 臨床前化合物庫 | NO PAINS 化合物庫 | 口服活性化合物庫 | 抗代謝疾病化合物庫 |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP7年
|
臺州市科瑞生物技術(shù)有限公司
|
2025-07-31 | |
¥1144.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2025-05-16 | |
¥1630.21 |
VIP11年
|
西格瑪奧德里奇(上海)貿(mào)易有限公司
|
2023-10-27 |